Diplomat Pharmacy Inc (DPLO) - Financial and Strategic SWOT Analysis Review
![](/report_cover/1896/diplomat-pharmacy-inc-dplo-financial-n-strategic-swot-analysis-review_en.gif)
Diplomat Pharmacy Inc (DPLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Diplomat Pharmacy Inc (Diplomat Pharmacy) is a specialty pharmacy services provider that offers personalized medication therapies and various other clinical services. It also provides pharmacy benefit management and customized care management solutions, including dispensing, delivery, dosing, and reimbursement of clinically intensive and high-cost specialty drugs. The company is licensed to dispense prescriptions in all the US states and territories. Diplomat Pharmacy’s solutions include patient care system, clinically based drug therapy management programs, counseling on adherence and side-effect management, drug-specific compliance programs, and clinical and administrative support services. It also provides financial assistance to patients and Hub Services for maintaining collaboration among participants in the specialty pharmacy system. Through Diplomat University, the company provides training to external professionals, including pharmacists, payors, pharmaceutical partners, and physicians, on the specialty pharmacy industry. Diplomat Pharmacy is headquartered in Flint, Michigan, the US.
Diplomat Pharmacy Inc Key Recent Developments
Apr 10,2019 Diplomat expands Adheretech relationship as program shows increased adherence and persistence
Mar 15,2019 Diplomat announces 4th quarter and 2018 year end financial results; provides revised 2019 guidance
Mar 15,2019 Diplomat Pharmacy names Daniel Davison as chief financial officer
Mar 08,2019 DIPLOMAT PHARMACY SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Diplomat Pharmacy, Inc. - DPLO
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Diplomat Pharmacy Inc (Diplomat Pharmacy) is a specialty pharmacy services provider that offers personalized medication therapies and various other clinical services. It also provides pharmacy benefit management and customized care management solutions, including dispensing, delivery, dosing, and reimbursement of clinically intensive and high-cost specialty drugs. The company is licensed to dispense prescriptions in all the US states and territories. Diplomat Pharmacy’s solutions include patient care system, clinically based drug therapy management programs, counseling on adherence and side-effect management, drug-specific compliance programs, and clinical and administrative support services. It also provides financial assistance to patients and Hub Services for maintaining collaboration among participants in the specialty pharmacy system. Through Diplomat University, the company provides training to external professionals, including pharmacists, payors, pharmaceutical partners, and physicians, on the specialty pharmacy industry. Diplomat Pharmacy is headquartered in Flint, Michigan, the US.
Diplomat Pharmacy Inc Key Recent Developments
Apr 10,2019 Diplomat expands Adheretech relationship as program shows increased adherence and persistence
Mar 15,2019 Diplomat announces 4th quarter and 2018 year end financial results; provides revised 2019 guidance
Mar 15,2019 Diplomat Pharmacy names Daniel Davison as chief financial officer
Mar 08,2019 DIPLOMAT PHARMACY SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Diplomat Pharmacy, Inc. - DPLO
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Diplomat Pharmacy Inc - Key Facts
Diplomat Pharmacy Inc - Key Employees
Diplomat Pharmacy Inc - Key Employee Biographies
Diplomat Pharmacy Inc - Major Products and Services
Diplomat Pharmacy Inc - History
Diplomat Pharmacy Inc - Company Statement
Diplomat Pharmacy Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Diplomat Pharmacy Inc - Business Description
Business Segment: PBM
Overview
Performance
Business Segment: Specialty
Overview
Performance
Diplomat Pharmacy Inc - SWOT Analysis
SWOT Analysis - Overview
Diplomat Pharmacy Inc - Strengths
Diplomat Pharmacy Inc - Weaknesses
Diplomat Pharmacy Inc - Opportunities
Diplomat Pharmacy Inc - Threats
Diplomat Pharmacy Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Diplomat Pharmacy Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Apr 10, 2019: Diplomat expands Adheretech relationship as program shows increased adherence and persistence
Mar 15, 2019: Diplomat announces 4th quarter and 2018 year end financial results; provides revised 2019 guidance
Mar 15, 2019: Diplomat Pharmacy names Daniel Davison as chief financial officer
Mar 08, 2019: DIPLOMAT PHARMACY SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Diplomat Pharmacy, Inc. - DPLO
Mar 04, 2019: EnvoyHealth to offer Mango Health mobile app
Feb 28, 2019: Diplomat announces resignation of Jeff Park from board of directors
Jan 07, 2019: Diplomat provides updated 2018 Guidance and Preliminary 2019 Outlook
Jan 07, 2019: Diplomat partners With CSI Specialty Group to expand health system services
Nov 26, 2018: Diplomat Pharmacy to ship certain medications in ClimaCell coolers
Aug 06, 2018: Diplomat announces 2nd quarter financial result
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Diplomat Pharmacy Inc - Key Facts
Diplomat Pharmacy Inc - Key Employees
Diplomat Pharmacy Inc - Key Employee Biographies
Diplomat Pharmacy Inc - Major Products and Services
Diplomat Pharmacy Inc - History
Diplomat Pharmacy Inc - Company Statement
Diplomat Pharmacy Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Diplomat Pharmacy Inc - Business Description
Business Segment: PBM
Overview
Performance
Business Segment: Specialty
Overview
Performance
Diplomat Pharmacy Inc - SWOT Analysis
SWOT Analysis - Overview
Diplomat Pharmacy Inc - Strengths
Diplomat Pharmacy Inc - Weaknesses
Diplomat Pharmacy Inc - Opportunities
Diplomat Pharmacy Inc - Threats
Diplomat Pharmacy Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Diplomat Pharmacy Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Apr 10, 2019: Diplomat expands Adheretech relationship as program shows increased adherence and persistence
Mar 15, 2019: Diplomat announces 4th quarter and 2018 year end financial results; provides revised 2019 guidance
Mar 15, 2019: Diplomat Pharmacy names Daniel Davison as chief financial officer
Mar 08, 2019: DIPLOMAT PHARMACY SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Diplomat Pharmacy, Inc. - DPLO
Mar 04, 2019: EnvoyHealth to offer Mango Health mobile app
Feb 28, 2019: Diplomat announces resignation of Jeff Park from board of directors
Jan 07, 2019: Diplomat provides updated 2018 Guidance and Preliminary 2019 Outlook
Jan 07, 2019: Diplomat partners With CSI Specialty Group to expand health system services
Nov 26, 2018: Diplomat Pharmacy to ship certain medications in ClimaCell coolers
Aug 06, 2018: Diplomat announces 2nd quarter financial result
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Diplomat Pharmacy Inc, Key Facts
Diplomat Pharmacy Inc, Key Employees
Diplomat Pharmacy Inc, Key Employee Biographies
Diplomat Pharmacy Inc, Major Products and Services
Diplomat Pharmacy Inc, History
Diplomat Pharmacy Inc, Other Locations
Diplomat Pharmacy Inc, Subsidiaries
Diplomat Pharmacy Inc, Key Competitors
Diplomat Pharmacy Inc, Ratios based on current share price
Diplomat Pharmacy Inc, Annual Ratios
Diplomat Pharmacy Inc, Annual Ratios (Cont...1)
Diplomat Pharmacy Inc, Annual Ratios (Cont...2)
Diplomat Pharmacy Inc, Interim Ratios
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Diplomat Pharmacy Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Diplomat Pharmacy Inc, Key Facts
Diplomat Pharmacy Inc, Key Employees
Diplomat Pharmacy Inc, Key Employee Biographies
Diplomat Pharmacy Inc, Major Products and Services
Diplomat Pharmacy Inc, History
Diplomat Pharmacy Inc, Other Locations
Diplomat Pharmacy Inc, Subsidiaries
Diplomat Pharmacy Inc, Key Competitors
Diplomat Pharmacy Inc, Ratios based on current share price
Diplomat Pharmacy Inc, Annual Ratios
Diplomat Pharmacy Inc, Annual Ratios (Cont...1)
Diplomat Pharmacy Inc, Annual Ratios (Cont...2)
Diplomat Pharmacy Inc, Interim Ratios
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Diplomat Pharmacy Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Diplomat Pharmacy Inc, Performance Chart (2014 - 2018)
Diplomat Pharmacy Inc, Ratio Charts
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
COMPANIES MENTIONED
Walgreens Boots Alliance, Inc.
Prime Therapeutics LLC
PharMedium Services LLC
Optum Inc
Express Scripts Holding Co
CVS Health Corp
Diplomat Pharmacy Inc, Performance Chart (2014 - 2018)
Diplomat Pharmacy Inc, Ratio Charts
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
COMPANIES MENTIONED
Walgreens Boots Alliance, Inc.
Prime Therapeutics LLC
PharMedium Services LLC
Optum Inc
Express Scripts Holding Co
CVS Health Corp